Covid 19 vaccine Pfizer JJ entry could still be months away
We Care...!!!

US pharma biggies Pfizer, Johnson & Johnson and Moderna might be amongst the potential gainers of the federal government’s determination to fast-track approvals for foreign-produced Covid-19 vaccines.
While Johnson & Johnson is eager to enter India and has held preliminary discussions for making use of for an emergency approval not too long ago, Pfizer withdrew in February from the race attributable to regulatory points.
The rollout from Pfizer and J&J may take a number of months as they should resolve their technique, sources informed TOI, including Pfizer might face points attributable to restricted vaccine manufacturing capability.
The mRNA vaccine from Moderna can be months away, with the corporate being in early talks with CSIR for a potential tie-up, in keeping with information studies.
Experts say Pfizer may have the first-mover benefit because it was the primary firm which utilized for emergency authorisation final 12 months in December, supplied it has sufficient doses for India.

Report

Leave a Reply

Your email address will not be published. Required fields are marked *

Translate »